Roche diagnostics Egypt launches \\\”Peptide for life\\\” initiative for better laboratory diagnosis of heart failure – Roche diagnostics Egypt launches \\\”Peptide for life\\\” initiative for better laboratory diagnosis of heart failure – Roche diagno

Roche diagnostics Egypt launches \\\”Peptide for life\\\” initiative for better laboratory diagnosis of heart failure – Roche diagnostics Egypt launches \\\”Peptide for life\\\” initiative for better laboratory diagnosis of heart failure – Roche diagno

Cairo: In an unprecedented step, Roche Diagnostics Egypt launched “Peptide for Life” initiative under the auspices of the Egyptian Society of Cardiology, for availing a better health care for patients with heart failure.

The initiative will focus on furnishing affordable certified laboratory testing of the gold standard biomarker in heart failure disease (Natriuretic peptide or NP) in the Egyptian medical laboratories, alongside raising the physicians’ awareness about the best use of it in various patient cases and its available testing sites.

To achieve this goal, Roche Diagnostics Egypt is tying up with the Egyptian Society of Cardiology, the largest local entity and main reference for Cardiology in Egypt, to form the Egyptian Heart Failure Working Group.

The Group will focus on boosting cardiologists’ understanding of the best practices for the optimal use of NP’s testing in the diagnosis, prognosis, and constant monitoring of patients for providing those with heart failure problems with a better care.

According to the US National Library of Medicine, NPs are substances produced by the heart, which can cause conditions known as heart failure when produced in high levels. Thus, the measurement of these vital indicators is considered vital for the diagnosis and follow-up of patients with heart failure.

Roche Diagnostics